Our recent
blog posts

National shortage of ADHD medication, Elvanse

Why is there a shortage of ADHD medication?  Last Autumn, the UK Government announced a shortage of medications for Attention Deficit Hyperactivity Disorder (ADHD) including Elvanse (lisdexamfetamine). The supply issues are international, and have been…

Read more
Introducing Veoza, the new menopause drug

What is Veoza? An alternative to HRT, Veoza (also known as fezolinetant) is a prescription-only, non-hormonal drug, that reduces menopausal hot flushes and night sweats. Menopause is a natural change in older women, but the…

Read more
Mounjaro: Dosages, availability in the UK and what we know so far

What do we know about weight loss drug Mounjaro? Developed by the US pharmaceutical company Eli Lilly, Mounjaro is a new weight loss drug coming to the UK next month. The drug comes in a…

Read more
Festive Opening Times & Order Cut-off 2023

We are quickly approaching the of the year and only a few weeks until Christmas. This year seems to have flown by faster than ever. As always, we want to make sure you receive your…

Read more
Prescription solutions for ADHD clinics: How to stay ahead in healthcare innovation

If you’re an ADHD clinic prescribing controlled drugs (CD) in the UK, you’re already acquainted with challenges that limit your growth. With a growing number of cases, and nearly 4% of the UK’s adult population…

Read more
ADHD medication in the UK: what are your options? 

Introduction ADHD (Attention Deficit & hyperactivity disorder) is a neurodevelopmental disorder affecting individuals’ ability to manage their energy levels, effectively impacting nearly 6.8% (366.3 million) adults worldwide.  This condition transcends age, impacting both children and…

Read more